A detailed history of Northwestern Mutual Wealth Management CO transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Northwestern Mutual Wealth Management CO holds 12,397 shares of VRTX stock, worth $5.59 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
12,397
Previous 15,942 22.24%
Holding current value
$5.59 Million
Previous $7.47 Million 22.85%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$460.0 - $505.78 $1.63 Million - $1.79 Million
-3,545 Reduced 22.24%
12,397 $5.77 Million
Q2 2024

Aug 15, 2024

BUY
$392.81 - $485.53 $3 Million - $3.71 Million
7,647 Added 92.19%
15,942 $7.47 Million
Q1 2024

May 15, 2024

SELL
$407.69 - $446.08 $131,276 - $143,637
-322 Reduced 3.74%
8,295 $3.47 Million
Q4 2023

Feb 13, 2024

BUY
$343.0 - $410.68 $174,930 - $209,446
510 Added 6.29%
8,617 $3.51 Million
Q3 2023

Nov 14, 2023

SELL
$338.18 - $362.46 $264,118 - $283,081
-781 Reduced 8.79%
8,107 $2.82 Million
Q2 2023

Aug 14, 2023

SELL
$314.42 - $351.91 $243,361 - $272,378
-774 Reduced 8.01%
8,888 $3.13 Million
Q1 2023

May 15, 2023

BUY
$283.23 - $323.1 $34,554 - $39,418
122 Added 1.28%
9,662 $3.04 Million
Q4 2022

Feb 21, 2023

BUY
$285.76 - $321.48 $118,876 - $133,735
416 Added 4.56%
9,540 $2.75 Million
Q3 2022

Nov 14, 2022

SELL
$273.83 - $305.53 $6,298 - $7,027
-23 Reduced 0.25%
9,124 $2.64 Million
Q2 2022

Aug 04, 2022

SELL
$234.96 - $292.55 $101,737 - $126,674
-433 Reduced 4.52%
9,147 $2.58 Million
Q1 2022

May 09, 2022

BUY
$221.42 - $260.97 $448,154 - $528,203
2,024 Added 26.79%
9,580 $2.5 Million
Q4 2021

Feb 03, 2022

BUY
$177.01 - $223.45 $353,134 - $445,782
1,995 Added 35.87%
7,556 $1.66 Million
Q3 2021

Nov 15, 2021

SELL
$181.39 - $202.99 $120,080 - $134,379
-662 Reduced 10.64%
5,561 $1.01 Million
Q2 2021

Aug 13, 2021

SELL
$187.49 - $221.1 $750,147 - $884,621
-4,001 Reduced 39.13%
6,223 $1.26 Million
Q1 2021

May 14, 2021

SELL
$207.02 - $241.31 $700,762 - $816,834
-3,385 Reduced 24.87%
10,224 $2.2 Million
Q4 2020

Feb 12, 2021

BUY
$207.01 - $276.09 $505,932 - $674,763
2,444 Added 21.89%
13,609 $3.22 Million
Q3 2020

Nov 13, 2020

BUY
$255.65 - $303.1 $2.1 Million - $2.49 Million
8,223 Added 279.5%
11,165 $3.04 Million
Q2 2020

Aug 14, 2020

BUY
$225.48 - $295.8 $174,296 - $228,653
773 Added 35.64%
2,942 $855,000
Q1 2020

May 08, 2020

BUY
$199.77 - $247.81 $53,538 - $66,413
268 Added 14.1%
2,169 $516,000
Q4 2019

Feb 13, 2020

SELL
$166.71 - $223.91 $54,680 - $73,442
-328 Reduced 14.72%
1,901 $416,000
Q3 2019

Nov 12, 2019

SELL
$166.23 - $187.09 $9,142 - $10,289
-55 Reduced 2.41%
2,229 $378,000
Q2 2019

Aug 12, 2019

BUY
$164.61 - $190.37 $20,082 - $23,225
122 Added 5.64%
2,284 $419,000
Q1 2019

May 10, 2019

BUY
$163.73 - $194.7 $46,008 - $54,710
281 Added 14.94%
2,162 $398,000
Q4 2018

Feb 12, 2019

SELL
$151.91 - $192.21 $9,114 - $11,532
-60 Reduced 3.09%
1,881 $312,000
Q3 2018

Nov 01, 2018

BUY
$167.73 - $192.74 $20,966 - $24,092
125 Added 6.88%
1,941 $374,000
Q2 2018

Aug 10, 2018

BUY
$145.72 - $169.96 $49,253 - $57,446
338 Added 22.87%
1,816 $309,000
Q1 2018

May 14, 2018

BUY
$151.6 - $177.13 $62,156 - $72,623
410 Added 38.39%
1,478 $241,000
Q4 2017

Jan 31, 2018

BUY
$137.28 - $155.55 $6,726 - $7,621
49 Added 4.81%
1,068 $160,000
Q3 2017

Nov 07, 2017

BUY
$148.13 - $162.24 $4,592 - $5,029
31 Added 3.14%
1,019 $155,000
Q2 2017

Aug 10, 2017

BUY
N/A
988
988 $127,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Northwestern Mutual Wealth Management CO Portfolio

Follow Northwestern Mutual Wealth Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwestern Mutual Wealth Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Northwestern Mutual Wealth Management CO with notifications on news.